SITC 2018 Abstracts • General Information

Submit an Abstract

Click here to submit a regular abstract, Young Investigator Award abstract or a late-breaking abstract application.

Continue scrolling or click the following links to learn more about specific abstract categories and timelines:

SITC 2018 Regular and Late-Breaking Abstract Guide

This printable, comprehensive guide includes all the information you need to know about the SITC abstract process. This guide includes:

  • Abstract guidelines
  • Eligibility
  • Selection criteria
  • Step-by-Step submission instructions
  • Presentation information
  • Abstract policies
Download the SITC 2018 Regular and Late-Breaking Abstract Guide

Reasons to Submit an Abstract to SITC 2018

  • Free submission for members and nonmembers. (View Important Submission Dates)
  • Young Investigator Awards are offered in conjunction with regular abstract submission.
  • All accepted abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal.
  • There are more than 59 oral presentation opportunities available.
  • The opportunity to present and discuss your research with luminaries in the immunotherapy field.

Important Abstract Dates

Regular and Late-Breaking

Date Details
April 3, 2018 Regular Abstracts, Young Investigator Award Abstracts, and Late-Breaking Abstracts Application Submission Site Opens
Aug. 1, 2018 Regular Abstracts, Young Investigator Award Abstracts, Late-Breaking Abstracts Application Site Closes at 5 p.m. PDT
Aug. 10, 2018 Late-Breaking Abstracts Application Notifications Sent
Aug. 15, 2018 Not Accepted Late-Breaking Abstracts Regular Abstracts Due at 5 p.m. PDT
Aug. 24, 2018 Late-Breaking Abstract Submission Site Opens for Accepted Applications
Aug. 31, 2018 Regular Abstract and Young Investigator Award Abstract Notifications Sent
Sept. 7, 2018 Regular Abstract Presentation Acceptance Confirmations Due
Deadline for Regular Abstract Withdrawals and Changes
Sept. 13, 2018 Late-Breaking Abstract Submission Site Closes at 5 p.m. PDT
Sept. 24, 2018 Late-Breaking Abstract Notifications Sent
Sept. 28, 2018 Late-Breaking Abstract Presentation Acceptance Confirmation Due
Deadline for Late-Breaking Abstract Withdrawals and Changes
Oct. 1, 2018 Regular Abstract Title and Author Information Released
Nov. 1, 2018 Late-Breaking Abstract Title and Author Information Released
Nov. 6, 2018 Embargo Lifted and Full Regular and Late-Breaking Abstracts Public at 8 a.m. EST
Regular Abstract Supplement Published in JITC
Nov. 7–11, 2018 33rd Annual Meeting and Pre-Conference Programs
Dec. 6, 2018 Late-Breaking Abstract Supplement Published in JITC

Abstract Information

Regular Abstract

Submit your latest research in the cancer immunotherapy field to the 33rd Annual Meeting for consideration as an oral abstract presentation, rapid oral abstract presentation, and/or poster abstract presentation from April 3 until 5 p.m. PDT on Aug. 1, 2018.

Late-Breaking Abstract

Late-breaking abstract (LBA) submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline.

All LBA submitters must submit an application by 5 p.m. PDT on Aug. 1, 2018 to be eligible for the LBA submission period. Applications will be reviewed and all submitters will be notified if they qualify to submit a late-breaking abstract during the submission period from Aug. 24, 2018 to 5 p.m. PDT on Sept. 13, 2018. If an application does not qualify for late-breaking abstract submission, the submitter will be notified by Aug. 10 and will have the opportunity to submit a regular abstract by 5 p.m. PDT on Aug. 15, 2018.

Late-breaking abstracts are considered for, but not limited to, oral abstract presentation during the Late-Breaking Abstract Sessions from Noon – 12:30 p.m. on Friday, Nov. 9 and from 11:35 a.m. – 12:05 p.m. on Saturday, Nov. 10.

Young Investigator Award Abstract

Regular abstracts with a primary and presenting author that is a student, postdoctoral research fellow, clinical fellow, or junior faculty with three or fewer years on staff and is a current SITC member, may be eligible to receive a Young Investigator Award. Young Investigator Award abstracts require a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author.

Those selected for the Presidential Travel Award will be invited to give an oral abstract presentation during the Presidential Session from 1:55 – 3:20 p.m. on Saturday, Nov. 10 , 2018.

For more information about the Young Investigator Awards as well as the criteria and eligibility, please click here.